SCHEMBL3524145

SCHEMBL3524145

CCCOc1cccc(-c2cc3ncc(-c4ccc(F)c(F)c4)nc3c(C(=O)NCC(=O)O)c2O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN3 Q9H6Z9 2/20 0.49
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.42
GAA P10253 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 3/20 0.40
ALOX12 P18054 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
RAB9A P51151 1/20 0.40
EGLN1 Q9GZT9 3/20 0.38
TP53 P04637 1/20 0.37
CTSA P10619 1/20 0.36
PRKACA P17612 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
PRKX P51817 1/20 0.36
PRKCQ Q04759 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3520245 0.92 EGLN3 (0.47) EGLN3ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL3524141 0.90 EGLN3 (0.49) EGLN3EGLN1DHODHNR4A2
SCHEMBL3761128 0.89 EGLN3 (0.55) EGLN3EGLN1
SCHEMBL3519608 0.87 EGLN3 (0.58) EGLN3RAB9AEGLN1
SCHEMBL3761625 0.83 EGLN3 (0.53) EGLN3KMT2AEGLN1MEN1
SCHEMBL3522299 0.83 EGLN3 (0.60) EGLN3EGLN1
SCHEMBL3520241 0.83 EGLN1 (0.48) EGLN3MAPTEGLN1TP53THRA
SCHEMBL3756274 0.82 EGLN3 (0.52) EGLN3EGLN1
SCHEMBL3524320 0.81 EGLN3 (0.49) EGLN3RAB9AEGLN1
SCHEMBL3756929 0.81 EGLN3 (0.53) EGLN3ALDH1A1KDM4ERAB9AEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP claimed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO claimed
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP disclosed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO disclosed